DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2234185/ptc-therapeutics-ptct-reports-q4-loss-lags-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2234185 Feb 29, 2024 - PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -182.76% and 2.80%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://seekingalpha.com/article/4675146-ptc-therapeutics-inc-ptct-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Feb 29, 2024 - PTC Therapeutics, Inc. (NASDAQ:NASDAQ:PTCT) Q4 2023 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsRon Aldridge - Senior Director,... 0

https://seekingalpha.com/article/4686527-ptc-therapeutics-inc-ptct-q1-2024-earnings-call-transcript?source=feed_sector_transcripts Apr 25, 2024 - PTC Therapeutics, Inc. (NASDAQ:NASDAQ:PTCT) Q1 2024 Earnings Conference Call April 25, 2024 4:30 PM ETCompany ParticipantsJane Hanlon - Associate Director... 0

https://www.zacks.com/stock/news/2225553/ptc-therapeutics-ptct-to-report-q4-results-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2225553 Feb 13, 2024 - PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2234255/here-s-what-key-metrics-tell-us-about-ptc-therapeutics-ptct-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2234255 Feb 29, 2024 - While the top- and bottom-line numbers for PTC Therapeutics (PTCT) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/stock/news/2243692/ptc-therapeutics-ptct-up-on-positive-regulatory-updates?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243692 Mar 20, 2024 - PTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to resubmit its application for Translarna to the regulatory body. Its shares rise on these updates. 0

https://www.zacks.com/stock/news/2244198/biotech-stock-roundup-gern-crnx-gain-on-updates-bmy-s-car-t-cell-therapy-news-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2244198 Mar 21, 2024 - Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates. 0

https://www.zacks.com/stock/news/2257703/ptc-therapeutics-ptct-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2257703 Apr 18, 2024 - PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2262892/compared-to-estimates-ptc-therapeutics-ptct-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2262892 Apr 25, 2024 - Although the revenue and EPS for PTC Therapeutics (PTCT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0